Search Results - "Griffith, Paige"

641 A pilot study of a DNAJB1-PRKACA fusion kinase peptide vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar hepatocellular carcinoma by Baretti, Marina, Ladle, Brian, Nauroth, Julie, Wang, Hao, Durham, Jennifer, Thoburn, Christopher, Ferguson, Anna, Thompson, Alex, Brancati, Madalena, Griffith, Paige, Kamdar, Zeal, Kirk, Allison, Zaidi, Neeha, Huff, Amanda, Ho, Won, Furth, Mark, Thomas, Paul, Jaffee, Elizabeth M, Yarchoan, Mark

“…BackgroundFibrolamellar carcinoma (FLC) is a form of liver cancer primarily affecting children and young adults. The signature genomic event is a chimeric…”
Get full text

Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic by Jia, Angela Y., Popovic, Aleksandra, Mohan, Aditya A., Zorzi, Jane, Griffith, Paige, Kim, Amy K., Anders, Robert A., Burkhart, Richard A., Lafaro, Kelly, Georgiades, Christos, Azad, Nilofer S., Liddell, Robert P., Baretti, Marina, Kamel, Ihab R., Narang, Amol, Yarchoan, Mark, Meyer, Jeffrey

“…Multidisciplinary care has been associated with improved survival in patients with primary liver cancers. We report the practice patterns and real world…”
Get full text

Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis by Gupta, Amol, Zorzi, Jane, Ho, Won Jin, Baretti, Marina, Azad, Nilofer Saba, Griffith, Paige, Dao, Doan, Kim, Amy, Philosophe, Benjamin, Georgiades, Christos, Kamel, Ihab, Burkhart, Richard, Liddell, Robert, Hong, Kelvin, Shubert, Christopher, Lafaro, Kelly, Meyer, Jeffrey, Anders, Robert, Burns III, William, Yarchoan, Mark

“…Health-related quality of life (HRQoL) is known to be an important prognostic indicator and clinical endpoint for patients with hepatocellular carcinoma (HCC)…”
Get full text

Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer Clinic by Li, Daniel, Jia, Angela Y, Zorzi, Jane, Griffith, Paige, Kim, Amy K, Dao, Doan, Anders, Robert A, Georgiades, Christos, Liddell, Robert P, Hong, Kelvin, Azad, Nilofer S, Ho, Won Jin, Baretti, Marina, Christenson, Eric, Baghdadi, Azarakhsh, Kamel, Ihab R, Meyer, Jeffrey, Ghabi, Elie, Burkhart, Richard A, Lafaro, Kelly, He, Jin, Shubert, Chris, Yarchoan, Mark

“…To compare liver cancer resectability rates before and during the COVID-19 pandemic. Liver cancers usually present with nonspecific symptoms or are diagnosed…”
Get full text

MANAGING TOXICITIES IN PATIENTS TREATED WITH FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS (FGFRI): THE ROLE OF THE ONCOLOGY NURSE by Griffith, Paige, Savastano, David M, Schreiber, Judith, Mahipal, Amit

“…Fibroblast growth factor receptors (FGFR) are receptor tyrosine kinases involved in a wide range of biological functions, including cell proliferation,…”
Get full text

Salvage ipilimumab plus nivolumab in advanced hepatocellular carcinoma after prior anti-PD-(L)1 blockade by Alden, Stephanie Leigh, Lim, Mir, Kao, Chester, Shu, Daniel, Singal, Amit G., Noonan, Anne M., Griffith, Paige, Baretti, Marina, Ho, Won Jin, Kamel, Ihab R., Yarchoan, Mark, Hsiehchen, David

“…4091 Background: Combination PD-(L)1/CTLA-4 blockade is approved in patients with advanced hepatocellular carcinoma (HCC) in the first line or after treatment…”
Get full text

Real world impact of hepatocellular carcinoma stage and hepatic function on health-related quality of life by Gupta, Amol, Zorzi, Jane, Ho, Won Jin, Baretti, Marina, Azad, Nilofer Saba, Griffith, Paige, Dao, Doan, Kim, Amy K., Philosophe, Benjamin, Georgiades, Christos, Kamel, Ihab R., Burkhart, Richard, Liddell, Robert, Hong, Kelvin, Shubert, Christopher, Lafaro, Kelly, Meyer, Jeffrey, Anders, Robert A., Burns, William, Yarchoan, Mark

“…e16215 Background: Health-Related Quality of Life (HRQoL) is an important prognostic indicator and clinical endpoint for patients with hepatocellular carcinoma…”
Get full text

Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma by Solipuram, Vinod, Baretti, Marina, Kim, Alexander Y., Chen, Lucy X., Fahrner, Jill A., Gunay‐Aygun, Meral, Peng, Xiao P., Hardenbergh, Dylan, Ferguson, Anna, Griffith, Paige, Wang, Yuxuan, Brancati, Madelena, Gopalakrishna, Harish, Kato, Tomoaki, Shubert, Chris, Laheru, Daniel, Yarchoan, Mark

Get full text

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors by Chen, Krista Y, Popovic, Aleksandra, Hsiehchen, David, Baretti, Marina, Griffith, Paige, Bista, Ranjan, Baghdadi, Azarakhsh, Kamel, Ihab R, Simon, Sanford M, Migler, Rachael D, Yarchoan, Mark

“…Fibrolamellar hepatocellular carcinoma (FLC) is a rare form of liver cancer primarily affecting children and young adults. Although considered a subset of…”
Get full text

Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New Challenge by Griffith, Paige, Jedrych, Jaroslaw, Sunshine, Joel, Laheru, Daniel A, Yarchoan, Mark

“…Specific fibroblast growth factor receptor (FGFR) inhibitors have been developed to treat malignancies harboring fusions or rearrangements in FGFR2 or FGFR3…”
Get full text

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma by Alden, Stephanie L, Lim, Mir, Kao, Chester, Shu, Daniel, Singal, Amit G, Noonan, Anne, Griffith, Paige, Baretti, Marina, Ho, Won Jin, Kamel, Ihab, Yarchoan, Mark, Hsiehchen, David

“…Combination anti-PD-(L)1/CTLA-4 blockade is approved in patients with hepatocellular carcinoma (HCC) in the first-line setting or after sorafenib, but whether…”
Get full text

Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC by Nakazawa, Mari, Fang, Mike, Vong, Tyrus, Zorzi, Jane, Griffith, Paige, Anders, Robert A, Oshima, Kiyoko, Kim, Amy K, Laurin, Jacqueline, Lafaro, Kelly J, Shubert, Christopher R, Burns, William R, He, Jin, Burkhart, Richard A, Philosophe, Benjamin, Meyer, Jeffrey, Liddell, Robert P, Georgiades, Christos, Hong, Kelvin, Ho, Won Jin, Baretti, Marina, Strauss, Alexandra T, Yarchoan, Mark

“…Surgical resection for localized hepatocellular carcinoma (HCC) is typically reserved for a minority of patients with favorable tumor features and anatomy…”
Get full text

Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New Challenge by Griffith, Paige, Jedrych, Jaroslaw, Sunshine, Joel, Laheru, Daniel A, Yarchoan, Mark

Get full text